BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 6594964)

  • 1. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J; Funke S; Holgado S; Choritz H; Georgii A
    Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases.
    Thiele J; Holgado S; Choritz H; Georgii A
    Scand J Haematol; 1983 Oct; 31(4):329-41. PubMed ID: 6578591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases.
    Thiele J; Holgado S; Choritz H; Georgii A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 41(1-2):67-81. PubMed ID: 6134385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloproliferative diseases with an elevated platelet count (in excess of 1,000,000/microliter): a clinicopathological study on 46 patients with special emphasis on primary (essential) thrombocythemia.
    Thiele J; Moedder B; Kremer B; Zankovich R; Fischer R
    Hematol Pathol; 1987; 1(4):227-37. PubMed ID: 3504437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic criteria of the myeloproliferative disorders (MPD): essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia.
    Michiels JJ
    Neth J Med; 1997 Aug; 51(2):57-64. PubMed ID: 9286142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
    Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
    Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders].
    Bobik R; Podolak-Dawidziak M; Kiełbiński M; Jeleń M; Wróbel T
    Acta Haematol Pol; 1995; 26(2):179-83. PubMed ID: 7653223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction.
    Thiele J; Titius BR; Kvasnicka HM; Rechmeier W; Fischer R
    Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders.
    Nafe R; Georgii A; Kaloutsi V; Fritsch RS; Choritz H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 61(2):111-6. PubMed ID: 1683718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Megakaryopoiesis in chronic myeloproliferative disorders].
    Nagasawa T
    Rinsho Ketsueki; 1993 May; 34(5):551-6. PubMed ID: 8315826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia.
    Thiele J; Schneider G; Hoeppner B; Wienhold S; Zankovich R; Fischer R
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):407-17. PubMed ID: 3140482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphometry of megakaryocytes for supporting the histologic diagnosis of chronic myeloproliferative diseases].
    Nafe R; Holgado de Colombo S; Choritz H; Georgii A
    Pathologe; 1995 Jan; 16(1):34-40. PubMed ID: 7886012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic megakaryocytic granulocytic myelosis-CMGM. A subtype of chronic myeloid leukemia.
    Georgii A; Vykoupil KF; Thiele J
    Virchows Arch A Pathol Anat Histol; 1980; 389(3):253-68. PubMed ID: 6935864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megakaryocyte precursors (pro- and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. An immunomorphometric study.
    Thiele J; Wagner S; Degel C; Dienemann D; Wienhold S; Zankovich R; Fischer R; Stein H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 58(4):295-302. PubMed ID: 1970693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities.
    Kaloutsi V; Fritsch RS; Buhr T; Restrepo-Specht I; Widjaja W; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(6):493-7. PubMed ID: 2058083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.